[FOR IMMEDIAT RELEASE: February 18, 2023] Vancouver, B.C. – Lab 915 Technologies Inc. was incorporated on February 17, 2023, so that the company may develop novel medical technology to better treat plantar fasciitis and achilles tendinopathy. The move unlocks access to various non-equity fundraising opportunities not limited to The National Research Council of Canada’s Industrial Research Assistance Program (NRC IRAP) and Mitacs which partners with Canadian academia, private industry and government through research and training programs in fields related to industrial and social innovation.
Based on personal experience and the adaptation of a customized orthotic which had significant positive impact on a family member’s physical health, the venture is dedicated to building a better world by enabling sufferers to return to the activities they love.
Affecting more than 15% of the general population, plantar fasciitis and achilles tendinopathy have significant effect on health and wellbeing including occupational, physical, and mental health. Through development and innovation, there is an opportunity to advance assistive device medical technology to improve treatment outcomes and ultimately improve the health and well-being of Canadians.
“We are excited to develop disruptive new medical device technology enabled through the incorporation of our company”, said Jolanda Peters, Founder at Lab 915 Technologies Inc. “We have listened to sufferers, heard their frustration with current treatment solutions and are dedicated to improving lives”.